✦ LIBER ✦

Galantamine Versus Risperidone Treatment of Neuropsychiatric Symptoms in Patients with Probable Dementia: An Open Randomized Trial

✍ Scribed by Bogaisky, Michael

Book ID: 124126503
Publisher: American Psychiatric Publishing Inc
Year: 2014
Tongue: English
Weight: 74 KB
Volume: 22
Category: Article
ISSN: 1064-7481
DOI: 10.1016/j.jagp.2014.04.010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Galantamine Versus Risperidone Treatment

Galantamine Versus Risperidone Treatment of Neuropsychiatric Symptoms in Patients with Probable Dementia: An Open Randomized Trial

✍ Freund-Levi, Yvonne; Jedenius, Erik; Tysen-Bäckström, Ann Christine; Lärksäter, 📂 Article 📅 2014 🏛 American Psychiatric Publishing Inc 🌐 English ⚖ 292 KB

Risperidone versus clozapine in the trea

Risperidone versus clozapine in the treatment of schizophrenic patients with acute symptoms: A double blind, randomized trial

✍ Heinrich, Kurt; Klieser, Eckhard; Lehmann, Erlo; Ḱinzler, Eckhart; Hruschka, Hel 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 490 KB

Amisulpride versus risperidone in the tr

Amisulpride versus risperidone in the treatment of depression in patients with schizophrenia: A randomized, open-label, controlled trial

✍ Sung-Wan Kim; Il-Seon Shin; Jae-Min Kim; Seung-Hyun Lee; Jeong-Hoon Lee; Bo-Hyun 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 416 KB

Effect of Music Therapy Versus Recreatio

Effect of Music Therapy Versus Recreational Activities on Neuropsychiatric Symptoms in Elderly Adults with DementiA: An Exploratory Randomized Controlled Trial

✍ Vink, Annemieke C.; Zuidersma, Marij; Boersma, Froukje; de Jonge, Peter; Zuidema 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Efficacy and safety of galantamine (remi

Efficacy and safety of galantamine (reminyl) for dementia in patients with Parkinson's disease (an open controlled trial)

✍ I. V. Litvinenko; M. M. Odinak; V. I. Mogil’naya; A. Yu. Emelin 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 139 KB

Baseline neuropsychiatric symptoms are e

Baseline neuropsychiatric symptoms are effect modifiers in Ginkgo biloba extract (EGb 761®) treatment of dementia with neuropsychiatric features. Retrospective data analyses of a randomized controlled trial

✍ R. Ihl; M. Tribanek; N. Bachinskaya 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 372 KB